Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki 036-8562, Japan.
Biochem Biophys Res Commun. 2013 Jan 4;430(1):394-9. doi: 10.1016/j.bbrc.2012.11.034. Epub 2012 Nov 15.
Histone deacetylase 6 (HDAC6) is a multifunctional cytoplasmic protein that plays an especially critical role in the formation of aggresomes, where aggregates of excess protein are deposited. Previous immunohistochemical studies have shown that HDAC6 accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies (DLB) as well as in glial cytoplasmic inclusions in multiple system atrophy (MSA). However, it is uncertain whether the level and activity of HDAC6 are altered in the brains of patients with neurodegenerative dementia. In the present study, we demonstrated that the level of HDAC6 was not altered in the temporal cortex of patients with Alzheimer's disease and DLB in comparison with controls. In contrast, the level of HDAC6 was significantly increased in the temporal cortex of patients with frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) and in the cerebellar white matter of patients with MSA. However, the level of acetylated α-tubulin, one of the substrates of HDAC6, was not altered in FTLD-TDP and MSA relative to controls. These findings suggest that the induced level of HDAC6 in the brain is insufficient for manifestation of its activity in FTLD-TDP and MSA.
组蛋白去乙酰化酶 6(HDAC6)是一种多功能细胞质蛋白,在形成聚集物(即过量蛋白质的沉积物)中起着尤为关键的作用。先前的免疫组织化学研究表明,HDAC6 在帕金森病和路易体痴呆(DLB)中的路易体以及在多系统萎缩症(MSA)中的神经胶质细胞质包涵体中积累。然而,尚不确定神经退行性痴呆患者大脑中 HDAC6 的水平和活性是否发生改变。在本研究中,我们发现与对照组相比,阿尔茨海默病和 DLB 患者的颞叶皮层中 HDAC6 的水平没有改变。相比之下,TDP-43 包涵体的额颞叶变性(FTLD-TDP)患者的颞叶皮层和 MSA 患者的小脑白质中 HDAC6 的水平显著增加。然而,与对照组相比,FTLD-TDP 和 MSA 中 HDAC6 的乙酰化 α-微管蛋白(其底物之一)的水平没有改变。这些发现表明,脑内诱导的 HDAC6 水平不足以使其在 FTLD-TDP 和 MSA 中表现出活性。